Internal Medicine, Infectious Disease · Avon Park, FL
NPI
1831153055
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3300 US 27 S
Avon Park, FL, 33825
Phone (863) 385-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
3,652 services
Medicare patients, 2024
143
Average age 74
Drug cost, 2024
$6.1M
7,545 prescriptions
Company payments, 2025
$794
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by J. Agustin Lacson was code 99214 (office e&m - established), 178 times for 88 patients. In total J. Agustin Lacson billed 3,652 services in 13 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 178 | 88 | $103.71 | $18K |
| 96365 Intravenous Infusion, Hydration | Office | 133 | 27 | $50.44 | $6,708 |
| 99213 Office E&M - Established | Office | 101 | 46 | $74.07 | $7,481 |
| 99205 Office E&M - New | Office | 75 | 75 | $183.42 | $14K |
| 99215 Office E&M - Established | Office | 61 | 40 | $151.11 | $9,218 |
By year: 2022 $104K for 59,748 services; 2023 $73K for 62,467 services; 2024 $57K for 3,652 services.
Medicare prescription drug claims, 2024
In 2024, the drug J. Agustin Lacson prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 514 prescriptions and refills. In total J. Agustin Lacson wrote 7,545 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 514 | 514 | 56 | $1.9M |
| Dovato Dolutegravir Sodium/Lamivudine | 276 | 280 | 27 | $773K |
| Atorvastatin Calcium Generic | 273 | 285 | 32 | $945 |
| Amlodipine Besylate Generic | 248 | 256 | 32 | $690 |
| Tivicay Dolutegravir Sodium | 235 | 235 | 32 | $517K |
| Levothyroxine Sodium Generic | 179 | 185 | 18 | $667 |
| Pantoprazole Sodium Generic | 166 | 180 | 27 | $882 |
| Hydrochlorothiazide Generic | 165 | 167 | 19 | $257 |
| Gabapentin Generic | 161 | 167 | 20 | $1,185 |
| Jardiance Empagliflozin | 146 | 152 | 27 | $87K |
| Prezcobix Darunavir/Cobicistat | 139 | 139 | 14 | $305K |
| Rosuvastatin Calcium Generic | 135 | 143 | 16 | $619 |
| Lisinopril Generic | 133 | 142 | 19 | $413 |
| Farxiga Dapagliflozin Propanediol | 127 | 133 | 15 | $70K |
| Tamsulosin Hcl Generic | 127 | 137 | 14 | $462 |
Brand drugs: 2,760 claims; generic drugs: 4,726 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid J. Agustin Lacson $794 ($794 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $254.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.